Figure 2. Syndecan-1 immunoexpression (arrows) in different pancreatic tumor groups. a. Mild expression in pancreatic carcinoma. b. Moderate expression in intraductal papillary mucinous neoplasms (IPMNs). c. Strong expression in mucinous cystic neoplasms (MCNs). Magnification 400x.